{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:31:31Z","timestamp":1768707091137,"version":"3.49.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/ijg.0b013e31815072fe","type":"journal-article","created":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T07:02:17Z","timestamp":1207724537000},"page":"233-237","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of Ocular Hypotensive Effect and Safety of Brinzolamide and Timolol Added to Latanoprost"],"prefix":"10.1097","volume":"17","author":[{"given":"Katsuya","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikahiro","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitaka","family":"Uji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00061198-199804000-00006","article-title":"Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States","volume":"7","author":"Kobelt-Nguyen","year":"1998","journal-title":"J Glaucoma"},{"key":"R2-13-20210208","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004170050124","article-title":"Comparison of two fixed combinations of latanoprost and timolol in open angle glaucoma","volume":"236","author":"Diestelhorst","year":"1988","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R3-13-20210208","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archopht.120.7.915","article-title":"Latanoprost and timolol combination therapy versus monotherapy: one-year randomized trial","volume":"120","author":"Higginbotham","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R4-13-20210208","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00417-002-0553-0","article-title":"A comparison of the fixed combination of latanoprost and timolol with its individual components","volume":"240","author":"Pfeiffer","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R5-13-20210208","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ophtha.2005.06.027","article-title":"A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components","volume":"113","author":"Diestelhorst","year":"2006","journal-title":"Ophthalmology"},{"key":"R6-13-20210208","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00061198-200108000-00012","article-title":"Comparison of the additive intraocular pressure-lowering effect of latanoprost and dolzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece","volume":"10","author":"Petounis","year":"2001","journal-title":"J Glaucoma"},{"key":"R7-13-20210208","first-page":"1258","article-title":"A new classification of stages of chronic glaucoma","volume":"76","author":"Kosaki","year":"1972","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"R8-13-20210208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-94-009-7272-8_5","article-title":"The relation between excavation and visual field in glaucoma patients with high and with low intraocular pressures","volume":"35","author":"Greve","year":"1983","journal-title":"Doc Ophthalmol Proc Ser"},{"key":"R9-13-20210208","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"R10-13-20210208","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"R11-13-20210208","first-page":"801","article-title":"Evaluation of the ocular hypotensive effect of the combination of latanoprost and two \u03b2-blockers","volume":"54","author":"Honda","year":"2003","journal-title":"Folia Ophthalmol Japonica"},{"key":"R12-13-20210208","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1185\/030079905X38222","article-title":"Intraocular pressure lowering effect of brinzolamide 1.0 percent as adjunctive therapy to latanoprost 0.005 percent in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study","volume":"21","author":"Shoji","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R13-13-20210208","first-page":"278","article-title":"Additive intraocular pressure lowering effect of various medications with latanoprost","volume":"36","author":"O'Connor","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R14-13-20210208","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1185\/030079904125004529","article-title":"Concomitant administration of travoprost and brinzolamide versus fixed latanoprost\/timolol combined therapy: three-month comparison of efficacy and safety","volume":"20","author":"Martinez-de-la-Casa","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R15-13-20210208","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0002-9394(99)00343-8","article-title":"The Brinzolamide Long-Term Therapy Study Group: the long-term safety and efficacy of brinzolamide 1% (Azopt) in patients with primary-open angle glaucoma or ocular hypertension","volume":"129","author":"March","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R16-13-20210208","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0002-9394(98)00095-6","article-title":"The Brinzolamide Primary Therapy Study Group: Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension","volume":"126","author":"Silver","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R17-13-20210208","first-page":"176","article-title":"Prostaglandins with vasodilating effects inhibit carbonic anhydrase while vasoconstrictive prostaglandins and leukotrienes B4 and C4 increase CA activity","volume":"32","author":"Puscas","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R18-13-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-5155(02)00667-6","article-title":"Influence of dorzolamide on corneal endothelium","volume":"47","author":"Inoue","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"R19-13-20210208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9394(98)00438-3","article-title":"Irreversible corneal decompensation in patients treated with topical dorzolamide","volume":"127","author":"Konowal","year":"1999","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00061198-200804000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:55:24Z","timestamp":1618278924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00061198-200804000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e31815072fe","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}